secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001437749-25-009132
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics engages ShareIntel to investigate potential illegal naked short selling
--------------------------------------------------------------------------------

- Engaged Shareholder Intelligence Services (ShareIntel) to probe potential illegal naked short selling and trading irregularities.
- Will use ShareIntel's DRIL-Down™ platform to analyze trading data from broker-dealers and clearing firms.
- CEO Thomas Jensen cites investor inquiries and notable stock volatility as drivers for the investigation.
- If violations of SEC Regulation SHO are found, Allarity will consider legal recourse against responsible parties.
- Investigation aims to protect shareholder value as the company advances clinical development of stenoparib.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925009132/0001437749-25-009132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925009132/allr20250324_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-009132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer